How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

19,732 results for

Obesity Surgery

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Gynaecologic Surgery in the Obese Patient

of obesity on gynaecologic surgery; and preoperative, intraoperative, and postoperative interventions to reduce risk. Evidence For this guideline, relevant studies were searched in the PubMed, EMBASE, Medline, and Cochrane databases. MeSH search terms included Gynecology, Obesity, Obesity/morbid, Overweight, Body mass index, Surgery, Laparoscopy, Laparotomy, Anesthesia, Intraoperative complications, Postoperative complications, Morbidity, and Mortality. Validation methods The content and recommendations (...) Gynaecologic Surgery in the Obese Patient Guideline No. 386-Gynaecologic Surgery in the Obese Patient - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 9, Pages 1356–1370.e7 Guideline No. 386-Gynaecologic Surgery in the Obese Patient x Paul J. Yong Correspondence Corresponding author: Dr. Paul Yong , MD , x Paul J. Yong Correspondence Corresponding author: Dr. Paul Yong Vancouver, BC x Jackie Thurston , MD

2019 Society of Obstetricians and Gynaecologists of Canada

2. Bariatric surgery to treat obesity in individuals under 21 years old

coverage policies of bariatric surgery in patients under 21. Overweight and obesity are among the main death risk and disease burden factors worldwide. In Argentina, according to the 2012 Global School-Based Student Health Survey, 28.5% and 5.9% of adolescents 13-15 years old have overweight and obesity, respectively. In our country, since 2009, our Mandatory Medical Plan covers surgical treatment for obesity starting at the age of 21. It is estimated that bariatric surgery might have a role (...) Bariatric surgery to treat obesity in individuals under 21 years old Bariatric surgery to treat obesity in individuals under 21 years old Bariatric surgery to treat obesity in individuals under 21 years old Rodríguez B, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made

2017 Health Technology Assessment (HTA) Database.

3. [Bariatric surgery as treatment for obesity in subjects over 65 years old]

[Bariatric surgery as treatment for obesity in subjects over 65 years old] [Bariatric surgery as treatment for obesity in subjects over 65 years old] [Bariatric surgery as treatment for obesity in subjects over 65 years old] Rodríguez B, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Rodríguez B, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L. [Bariatric surgery as treatment for obesity in subjects over 65 years old] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rapida No 508. 2017 Authors' conclusions Low-quality evidence shows that bariatric surgery might be considered

2017 Health Technology Assessment (HTA) Database.

4. Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities. Full Text available with Trip Pro

Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities. The association of bariatric surgery and specialized medical obesity treatment with beneficial and detrimental outcomes remains uncertain.To compare changes in obesity-related comorbidities in patients with severe obesity (body mass index ≥40 or ≥35 and at least 1 comorbidity) undergoing bariatric surgery or specialized medical treatment.Cohort study (...) with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).Bariatric surgery (n = 932, 92% gastric bypass) or specialized medical treatment (n = 956) including individual or group-based lifestyle intervention programs.Primary

2018 JAMA

5. Costs and outcomes of increasing access to bariatric surgery for obesity: cohort study and cost-effectiveness analysis using electronic health records Full Text available with Trip Pro

Costs and outcomes of increasing access to bariatric surgery for obesity: cohort study and cost-effectiveness analysis using electronic health records Costs and outcomes of increasing access to bariatric surgery for obesity: Cohort study and cost-effectiveness analysis using electronic health records Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose (...) a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Increasing access to bariatric surgery for people with morbid obesity improves health outcomes at relatively low cost. {{author}} {{($index , , , , , , , , & . Martin C Gulliford 1, 2, * , Judith Charlton 1 , Helen P Booth 1 , Alison Fildes 1 , Omar Khan 3 , Marcus Reddy 3 , Mark Ashworth 1 , Peter Littlejohns

2016 NIHR HTA programme

6. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. Full Text available with Trip Pro

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. Although metabolic surgery (defined as procedures that influence metabolism by inducing weight loss and altering gastrointestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascular outcomes has been less well characterized.To investigate the relationship between metabolic surgery and incident major adverse cardiovascular events (...) (MACE) in patients with type 2 diabetes and obesity.Of 287 438 adult patients with diabetes in the Cleveland Clinic Health System in the United States between 1998 and 2017, 2287 patients underwent metabolic surgery. In this retrospective cohort study, these patients were matched 1:5 to nonsurgical patients with diabetes and obesity (body mass index [BMI] ≥30), resulting in 11 435 control patients, with follow-up through December 2018.Metabolic gastrointestinal surgical procedures vs usual care

2019 JAMA

7. Surgery for the treatment of obesity in children and adolescents. Full Text available with Trip Pro

Surgery for the treatment of obesity in children and adolescents. Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences.To assess the effects of surgical interventions for treating obesity in childhood and adolescence.We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 2015). References of identified (...) studies and systematic reviews were checked. No language restrictions were applied.We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow-up. Interventions that specifically dealt with the treatment of eating disorders or type 2 diabetes, or included participants with a secondary or syndromic cause of obesity were excluded. Pregnant females were also excluded.Two review authors

2015 Cochrane

8. Bariatric Surgery for the Long-Term Treatment of Obesity: A Review of the Clinical Effectiveness and Cost-Effectiveness

Bariatric Surgery for the Long-Term Treatment of Obesity: A Review of the Clinical Effectiveness and Cost-Effectiveness Bariatric Surgery for the Long-Term Treatment of Obesity: A Review of the Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Bariatric Surgery for the Long-Term Treatment of Obesity: A Review of the Clinical Effectiveness and Cost-Effectiveness Bariatric Surgery for the Long-Term Treatment of Obesity: A Review of the Clinical Effectiveness (...) and Cost-Effectiveness Published on: July 20, 2016 Project Number: RC0789-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the long-term clinical effectiveness of bariatric surgery for the treatment of obesity and morbid obesity? What is the long-term cost-effectiveness of bariatric surgery for the treatment of obesity and morbid obesity? Key Message At five years follow-up, bariatric surgeries lead to a statistically

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

9. Long-Term Weight Regain Following Bariatric Surgery for the Treatment of Obesity: Clinical Evidence

Long-Term Weight Regain Following Bariatric Surgery for the Treatment of Obesity: Clinical Evidence Long-Term Weight Regain Following Bariatric Surgery for the Treatment of Obesity: Clinical Evidence | CADTH.ca Find the information you need Long-Term Weight Regain Following Bariatric Surgery for the Treatment of Obesity: Clinical Evidence Long-Term Weight Regain Following Bariatric Surgery for the Treatment of Obesity: Clinical Evidence Published on: September 13, 2016 Project Number: RA0865 (...) -000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical evidence regarding long-term weight regain following bariatric surgery for the treatment of obesity? Key Message One health technology assessment, two systematic reviews, and 11 non-randomized studies were identified regarding long-term weight regain following bariatric surgery for the treatment of obesity. Tags bariatric surgery, body weight changes, weight gain

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

10. The Risk of Post-operative Complications in Super-Super Obesity Compared to Super Obesity in Accredited Bariatric Surgery Centers. (Abstract)

The Risk of Post-operative Complications in Super-Super Obesity Compared to Super Obesity in Accredited Bariatric Surgery Centers. The prevalence of super obesity (SO, BMI > 50.0 kg/m2) and super-super obesity (SSO, BMI > 60 kg/m2) is increasing. Current data are limited and discrepant on the relationship between SSO and post-bariatric surgery complication risk. We hypothesized there would be increased complications for both laparoscopic Roux-en-Y gastric bypass (LRYGB) and sleeve gastrectomy (...) (LSG) in SSO compared to SO, but the relative risk (RR) would support the use of LSG in SSO patients.Metabolic and Bariatric Surgery Accreditation and Quality Improvement 2016 data were queried for SO and SSO patients undergoing LRYGB or LSG. Thirty-day post-operative complications were calculated. Univariate analyses were performed with a χ2 or Student's t test. Comparisons between multiple groups were performed using a one-way ANOVA. Statistical significance was defined as p < 0.05.A total

2019 Obesity Surgery

11. The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery-a German Nationwide Register-Based Cohort Study (StuDoQ|MBE). (Abstract)

The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery-a German Nationwide Register-Based Cohort Study (StuDoQ|MBE). To examine the relationship between Edmonton Obesity Staging System (EOSS) and perioperative complications as well as surgical procedure.The application of EOSS for the selection of patients with obesity is a more comprehensive measure of obesity-related diseases and a predictor of mortality than body mass (...) index (BMI).This was a nationwide cohort study using prospectively inserted data from the German register for obesity and metabolic surgery StuDoQ|MBE. All patients undergoing sleeve gastrectomy (SG), Roux-en Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB) between February 2015 and July 2017 as a primary treatment for severe obesity were included. Data included gender, age, BMI, ASA score, EOSS, early postoperative complications next to the Clavien-Dindo grading system

2019 Obesity Surgery

12. Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)". Full Text available with Trip Pro

Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)". 30615508 2019 01 07 1524-4539 139 2 2019 Jan 08 Circulation Circulation Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady

2019 Circulation Controlled trial quality: uncertain

13. Lack of Improvement of Sperm Characteristics in Obese Males After Obesity Surgery Despite the Beneficial Changes Observed in Reproductive Hormones. (Abstract)

Lack of Improvement of Sperm Characteristics in Obese Males After Obesity Surgery Despite the Beneficial Changes Observed in Reproductive Hormones. Even though obesity surgery normalizes circulating testosterone concentrations in males with obesity-associated secondary hypogonadism, its impact on spermatogenesis remains controversial. We aimed to evaluate sperm characteristics in obese men after bariatric surgery as well as changes in reproductive hormones.Twenty severely obese men (body mass (...) index (BMI) ≥ 35 kg/m2) were evaluated before and 2 years after bariatric surgery. The serum was assayed for insulin, leptin, kisspeptin, and inhibin B, among other hormones. Homeostasis model assessment of insulin resistance (HOMA-IR) was estimated. We used World Health Organization reference values for sperm analysis.After surgery, serum total testosterone, calculated free testosterone, inhibin B, and kisspeptin increased, whereas fasting insulin, HOMA-IR, and leptin concentrations decreased

2019 Obesity Surgery

14. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension) Full Text available with Trip Pro

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension) Recent research efforts on bariatric surgery have focused on metabolic and diabetes mellitus resolution. Randomized trials designed to assess the impact of bariatric surgery in patients with obesity and hypertension are needed.In this randomized, single-center, nonblinded trial, we included patients with hypertension (using ≥2 (...) . Waist circumference, body mass index, fasting plasma glucose, glycohemoglobin, low-density lipoprotein cholesterol, triglycerides, high-sensitivity C-reactive protein, and 10-year Framingham risk score were lower in the gastric bypass than in the control group.Bariatric surgery represents an effective strategy for blood pressure control in a broad population of patients with obesity and hypertension.URL: https://clinicaltrials.gov. Unique identifier: NCT01784848.© 2017 The Authors.

2017 EvidenceUpdates

15. Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients. (Abstract)

Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients. The association between bariatric surgery (BS) and the prevention of type 2 diabetes (T2D) and its complications in patients with obesity has been rarely addressed in large, nationwide database studies.To estimate the preventive effect of BS against T2D and its vascular complications in patients with obesity without co (...) with obesity by 82%. SG and GB give comparable results and both are more effective than AGB.Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

2019 Surgery for Obesity and Related Diseases

16. Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient

Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity in a high-risk patient 1 Public Summary Document Application No. 1515 Endoscopic placement and removal of an intragastric balloon for the management of moderate obesity in patients with type 2 diabetes mellitus who have failed first-line treatments Applicant: Apollo Endosurgery Australia Date of MSAC consideration: MSAC 76 th Meeting, 1-2 August 2019 Context for decision: MSAC makes (...) with the early removal may be high, and weight loss and quality of life benefits may not be achieved for these patients. MSAC noted that the financial impact was also highly uncertain as the proportion of eligible patients expected to receive an IGB was based on current uptake of bariatric surgery. The financial impact could be profoundly affected if the proposed MBS item descriptor applies to the 4.25 million obese patients in Australia. MSAC noted the negative feedback that some consumers have reported

2019 Medical Services Advisory Committee

17. Obese, overweight with risk factors: liraglutide (Saxenda)

Obese, overweight with risk factors: liraglutide (Saxenda) Obese, o Obese, ov verweight with risk factors: lir erweight with risk factors: liraglutide aglutide (Sax (Saxenda) enda) Evidence summary Published: 27 June 2017 nice.org.uk/guidance/es14 pathways K Ke ey points y points The content of this evidence summary was up-to-date in June 2017. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up- to-date information. Regulatory (...) status: Regulatory status: New medicine. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide (Saxenda) received a European marketing authorisation in March 2015 and was launched in the UK in January 2017. It is licensed as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial BMI of: 30 kg/m² or more (obese), or from 27 kg/m² to less than 30 kg/m² (overweight) in the presence of at least one weight

2017 National Institute for Health and Clinical Excellence - Advice

18. The impact of bariatric surgery on asthma control differs among obese individuals with reported prior or current asthma, with or without metabolic syndrome. Full Text available with Trip Pro

The impact of bariatric surgery on asthma control differs among obese individuals with reported prior or current asthma, with or without metabolic syndrome. Both obesity and the metabolic syndrome have been independently associated with increased asthma morbidity. However, it is unclear whether metabolic syndrome limits the beneficial effects of weight loss on asthma.To evaluate whether bariatric weight loss is associated with improved asthma control, and whether this association varies (...) by metabolic syndrome status.We determined the changes in asthma control, defined by the Asthma Control Test (ACT), before and after bariatric surgery among participants with asthma in the multi-center Longitudinal Assessment of Bariatric Surgery (LABS) study, stratifying our analysis by the presence or absence of metabolic syndrome.Among 2,458 LABS participants, 555 participants had an asthma diagnosis and were included in our analysis. Of these, 78% (n = 433) met criteria for metabolic syndrome (MetSyn

2019 PLoS ONE

19. Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery. Full Text available with Trip Pro

Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery. The controlled attenuation parameter (CAP) using FibroScan (Echosens, Paris, France) M or XL probe has been developed for liver steatosis assessment. However, CAP performs poorly in patients with high body mass index. The aim of our study was to assess whether CAP is overestimated using the standard XL probe in patients with morbid obesity, and in the case (...) of an overestimation, to reprocess the data at a greater depth to obtain the appropriate CAP (CAPa).We conducted an observational prospective cohort study on a total of 249 severely obese patients admitted to our institution to undergo sleeve gastrectomy. Patients had a liver biopsy performed during the surgery and a CAP measurement during the 15 days preceding biopsy. Patient files were reprocessed retrospectively by an algorithm, blinded to the patients' clinical data. The algorithm automatically assessed

2019 PLoS ONE

20. Ophthalmologic evaluation of severely obese patients undergoing bariatric surgery: A pilot, monocentric, prospective, open-label study. Full Text available with Trip Pro

Ophthalmologic evaluation of severely obese patients undergoing bariatric surgery: A pilot, monocentric, prospective, open-label study. The aim of this study was to investigate the pathogenic role of obesity on blinding eye diseases in a population of severely obese patients with no history of eye diseases, and to verify whether weight loss induced by bariatric surgery may have a protective effect.This was a pilot, monocentric, prospective, and open label study conducted at the University (...) with an increase in retinal nerve fiber layer thickness and minimum foveal thickness values in both eyes (p<0.05).The results of this study suggest that obese patients may have a greater susceptibility to develop glaucomatous optic nerve head damage and age-related macular degeneration. Moreover, weight reduction and improvement of comorbidities obtained by bariatric surgery may be effective in preventing eye disease development by improving retinal nerve fiber layer and foveal thickness.

2019 PLoS ONE

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>